Journal
EMERGING INFECTIOUS DISEASES
Volume 12, Issue 4, Pages 687-688Publisher
CENTER DISEASE CONTROL
DOI: 10.3201/eid1204.041256
Keywords
-
Categories
Ask authors/readers for more resources
Patients treated in Peru for multidrug-resistant tuberculosis (MDR-TB) were followed-up for a median of 67 months. Among 86 patients considered cured after completion of treatment, 97% remain healthy; 1 patient relapsed. Employment increased from 34% before treatment to 71 %. We observed favorable long-term outcomes among MDR-TB patients.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
